Wound Management Guide Digital

2016 WOUND CARE
PRODUCT SELECTION GUIDE

1
How to Use This Guide*
This guide is intended to be used as a wound management resource for all members of the
healthcare team involved in the assessment and management of wounds. This resource
includes images to help serve as a reference for you regarding wound severity and when used
in conjunction with holistic patient assessment helps you identify the corresponding Acelity
wound product(s) that may be appropriate for the management and treatment of individual
wounds.
Follow these three steps to use the guide:

1. Use the Table of Contents on page three (3) to find the appropriate page number of the
wound that you are assessing.
2. Find the appropriate treatment for the wound and your assessment.
3. M
ove down the chart to see the Acelity product(s) that may be appropriate for your
patients and go to the referenced page.
*Guide and references are to be used in conjunction with good clinical practice; utilize appropriate debridement and/or antibiotics where necessary. Untreated osteomyelitis is contraindicated for use
with V.A.C. Negative Pressure Wound Therapy.
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for all KCI and Systagenix products and therapies. Prior to the use of any medical device, it is
important for the provider to consult the treating physician and read and understand all Instructions for Use, including Safety Information, Dressing Application Instructions, and Therapy Device
Instructions. Rx only.
2
Table of Contents
Wound Classification Systems
Diabetic Foot Ulcer Wagner Grading System. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 4
Pressure Ulcer Classification System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 5
Comprehensive Classification System for Chronic Venous Disorders (CEAP) . . . . . . . . . . . . . . . . . . . . . . . . . . . Page 7
Surgical Site Infection Definitions . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . .Page 8
General Product Selection

Venous Leg Ulcers . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 12
Diabetic Foot Ulcers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 14
Pressure Ulcers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 16
Non-Healing Surgical Wounds. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 18
Arterial Ulcers. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 20
Acelity Products
Negative Pressure Wound Therapy. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 22
Disposable NPWT. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 30
Advanced Wound Dressings . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 31
Regenerative Tissue Matrix. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 42
Open Abdomen Management . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 43
Incision Management System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 44
Epidermal Harvesting System . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 45
Wound Glossary. . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 46
3
Wound Classification Systems
Diabetic Foot Ulcer Wagner Grading System
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Grade 5

Intact Skin Superficial ulcer Ulcers extend Deep ulcer with Gangrene of Midfoot
of skin or into tendon, osteomyelitis toes or forefoot or hindfoot
subcutaneous bone, or joint or abscess gangrene
tissue capsule
4
Pressure Ulcer Classification System
Pressure Ulcer Classification System*

Pressure Ulcer Stages/CAtegories
Category/Stage I: Non-blanchable erythema
Intact skin with non-blanchable redness of a localized area usually over a bony prominence. Darkly pigmented skin may not have visible blanching; its color may differ
from the surrounding area. The area may be painful, firm, soft, warmer or cooler as compared to adjacent tissue. Category I may be difficult to detect in individuals
with dark skin tones. May indicate at risk persons.
Category/Stage II: Partial thickness

Partial thickness loss of dermis presenting as a shallow open ulcer with a red pink wound bed, without slough. May also present as an intact or open/ruptured
serum-filled or sero-sanginous filled blister. Presents as a shiny or dry shallow ulcer without slough or bruising.** This category should not be used to describe skin
tears, tape burns, incontinence associated dermatitis, maceration or excoriation.
Category/Stage III: Full thickness skin loss

Full thickness tissue loss. Subcutaneous fat may be visible but bone, tendon or muscle are not exposed. Slough may be present but does not obscure the depth
of tissue loss. May include undermining and tunneling. The depth of a Category/Stage III pressure ulcer varies by anatomical location. The bridge of the nose, ear,
occiput and malleolus do not have (adipose) subcutaneous tissue and Category/Stage III ulcers can be shallow. In contrast, areas of significant adiposity can develop
extremely deep Category/Stage III pressure ulcers. Bone/tendon is not visible or directly palpable.
Category/Stage IV: Full thickness tissue loss

Full thickness tissue loss with exposed bone, tendon or muscle. Slough or eschar may be present. Often includes undermining and tunneling. The depth of a Cate-
gory/Stage IV pressure ulcer varies by anatomical location. The bridge of the nose, ear, occiput and malleolus do not have (adipose) subcutaneous tissue and these
ulcers can be shallow. Category/Stage IV ulcers can extend into muscle and/or supporting structures (e.g., fascia, tendon or joint capsule) making osteomyelitis or
osteitis likely to occur. Exposed bone/muscle is visible or directly palpable.
Additional Categories/Stages for the USA

Unstageable/Unclassified: Full thickness skin or tissue loss depth unknown
Full thickness tissue loss in which actual depth of the ulcer is completely obscured by slough (yellow, tan, gray, green or brown) and/or eschar (tan, brown or black)
in the wound bed. Until enough slough and/or eschar are removed to expose the base of the wound, the true depth cannot be determined; but it will be either a
Category/Stage III or IV. Stable (dry, adherent, intact without erythema or fluctuance) eschar on the heels serves as the bodys natural (biological) cover and should
not be removed.
Suspected Deep Tissue Injury depth unknown

Purple or maroon localized area of discolored intact skin or blood-filled blister due to damage of underlying soft tissue from pressure and/or shear. The area may be
preceded by tissue that is painful, firm, mushy, boggy, warmer or cooler as compared to adjacent tissue. Deep tissue injury may be difficult to detect in individuals
with dark skin tones. Evolution may include a thin blister over a dark wound bed. The wound may further evolve and become covered by thin eschar. Evolution may
be rapid exposing additional layers of tissue even with optimal treatment.
*National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel. Pressure Ulcer Prevention and Treatment: Clinical Practice Guideline. Washington, DC: National Pressure Ulcer Advisory Panel, 2009.
**Bruising indicates deep tissue injury.
5
Pressure Ulcer Classification System
Stage I: Stage II: Stage III:

Skin is intact with non-blanchable Shiny or dry shallow ulcer. There is Full thickness tissue loss without
redness over a bony area. The area partial thickness loss of dermis in a bone, tendon, or muscle exposure.
may be painful, firmer, softer, or shallow open ulcer, without slough. Subcutaneous fat may be visible.
different in temperature compared The depth of the ulcer varies with
to the surrounding area. Darker skin the location.
tones may not show differences.
Stage IV: Unstageable: Suspected Deep Tissue Injury:

Full thickness tissue loss with Full thickness tissue loss with slough Discolored purple or maroon area or blood-
exposed bone, tendon, or muscle. obscuring the ulcer depth and/or filled blister due to underlying soft tissue
The depth of the ulcer varies by eschar in the wound bed. Stage cant be damage from pressure and/or shear. Tissue
anatomical location. determined until slough and eschar are may be painful, firm, mushy, warmer, or
removed but is either Stage III or IV. cooler compared to adjacent tissue.
National Pressure Ulcer Advisory Panel and European Pressure Ulcer Advisory Panel. Pressure Ulcer Prevention and Treatment: Clinical Practice Guideline. Washington, DC: National Pressure Ulcer Advisory Panel, 2009.
NPUAP copyright and used with permission
6
Comprehensive Classification System for Chronic Venous Disorders (CEAP)
Comprehensive Classification System for Chronic Venous Disorders (CEAP)
C1- telangiectasias or C2- varicose veins C3- edema C4- lipodermatosclerosis C5- ulcer scar C6- active ulcer
reticular veins and eczema
Classification Description Classification of Venous Ulcers Etiology*

C0 No visible or palpable signs of venous disease EC Congenital EP Primary
ES Secondary (usually due to prior DVT)
C1 Telangiectasias or reticular veins
C2 Varicose veins Anatomy*
C3 Edema AS Superficial veins AP Perforating veins AD Deep veins
C4a Milder skin changes due to venous disorders (pigmentation, eczema) Pathophysiology*
C4b Severe skin changes due to venous disorders (dermatosclerosis, atrophie blanche) PR - Reflux PO - Obstruction
C5 C4 along with healed ulcers
*Fronek HS and Bergan JJ. The Fundamentals of Phlebology: Venous Disease for Clinicians, 2004: 151
C6 Skin changes with active ulcers
7
Surgical Site Infection Definitions
Surgical Site Infection (SSI) Definitions
Surgical Site Infection Criteria

Criterion Surgical Site Infection (SSI)
Superficial Must meet the following criteria:
Incisional Infection occurs within 30 days after any NHSN operative procedure (where day 1 = the procedure date), including those coded as OTH*
SSI AND
involves only skin and subcutaneous tissue of the incision
AND
patient has at least one of the following:
a. purulent drainage from the superficial incision.
b. organisms isolated from an aseptically-obtained culture from the superficial incision or subcutaneous tissue.
c. superficial incision that is deliberately opened by a surgeon, attending physician** or other designee and is culture positive or not cultured
AND
patient has at least one of the following signs or symptoms: pain or tenderness; localized swelling; erythema; or heat. A culture negative finding does not meet this criterion.
d. diagnosis of superficial incisional SSI by the surgeon or attending physician** or other designee.
*List of ICD-9-CM Codes. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nhsn/XLS/ICD-9-cmCODEScurrent.xlsx Published October 1, 2009. Updated May 11,2015. Accessed October 1, 2015.
** The term attending physician for the purposes of application of the NHSN SSI criteria may be interpreted to mean the surgeon(s), infectious disease, other physician on the case, emergency physician or physicians
designee (nurse practitioner or physicians assistant).
Comments There are two specific types of superficial incisional SSIs:

1. Superficial Incisional Primary (SIP) a superficial incisional SSI that is identified in the primary incision in a patient that has had an operation
with one or more incisions (e.g., C-section incision or chest incision for CBGB)
2. Superficial Incisional Secondary (SIS) a superficial incisional SSI that is identified in the secondary incision in a patient that has had an operation
with more than one incision (e.g., donor site incision for CBGB)
Criterion Surgical Site Infection (SSI) Criterion Surgical Site Infection (SSI)
Deep Must meet the following criteria: Organ/ Must meet the following criteria:
Incisional Infection occurs within 30 or 90 days after the NHSN operative procedure Space SSI Infection occurs within 30 or 90 days after the
SSI (where day 1 = the procedure date) according to the list on page 9 NHSN operative procedure (where day 1 = the
AND procedure date) according to the list on page 9
Involves deep soft tissures of the incision (e.g., fascial and muscle layers) AND
AND Infection involves any part of the body deeper than the
Patient has at least one of the following: fascial/muscle layers, that is opened or manipulated
a. purulent drainage from the deep incision. during the operative procedure
b. a deep incision that spontaneously dehisces, or is deliberatelyopened or aspirated by a AND
surgeon, attending physician* or other designee and is cultured positive or not cultured Patient has at least one of the following:
AND
patient has at least one of the following signs or symptoms: fever (>38O C); localized pain a. p urulent drainage from a drain that is placed
tenderness. A culture negative finding does not meet the criterion. into the organ/space (e.g., closed suction drainage
c. an abscess or other evidence of infection involving the deep incision that is detected system, open drain, T-tube drain, CT guided drainage)
on gross anatomical or histopathologic exam, or imaging test. b. o rganisms isolated from an aseptically-obtained
*The term attending physician for the purposes of application of the NHSN SSI criteria may be interpreted to mean the surgeon(s), culture of fluid or tissue in the organ/space
infectious disease, other physician on the case, emergency physician or physicians designee (nurse practitioner or physicians assistant). c. an abscess or other evidence of infection
involving the organ/space that is detected on gross
Comments There are two specific types of deep incisional SSIs: anatomical or histopathologic exam, or imaging test
1. Deep Incisional Primary (DIP) a deep incisional SSI that is identified in a primary incision in a AND
patient that has had an operation with one or more incisions (e.g., C-section incision or chest Meets at least one criterion for a specific organ/
incision for CBGB) space infection site listed on page 10. These criteria
2. D eep Incisional Secondary (DIS) a deep incisional SSI that is identified in the secondary incision in are in the Surveillance Definitions for Specific Types
a patient that has had an operation with more than one incision (e.g., donor site incision for CBGB) of Infections chapter.
8
Surgical Site Infection Definitions
Surveillance Period for Deep Incisional or Organ/Space SSI Following Selected NHSN Operative Procedure Categories. Day 1 = the date of the procedure.
30-day Surveillance 90-day Surveillance

Code Operative Procedure Code Operative Procedure Code Operative Procedure
AAA Abdominal aortic aneurysm repair LAM Laminectomy BRST Breast surgery
AMP Limb amputation LTP Liver transplant CARD Cardiac surgery
APPY Appendix surgery NECK Neck surgery CBGB Coronary artery bypass graft with both chest and donor site incisions
AVSD Shunt for dialysis NEPH Kidney surgery CBGC Coronary artery bypass graft with chest incision only
BILI Bile duct, liver or pancreatic surgery OVRY Ovarian surgery CRAN Craniotomy
CEA Carotid endarterectomy PRST Prostate surgery FUSN Spinal fusion
CHOL Gallbladder surgery REC Rectal surgery FX Open reduction of fracture
COLO Colon surgery SB Small bowel surgery HER Herniorrhaphy
CSEC Cesarean section SPLE Spleen surgery HPRO Hip prosthesis
GAST Gastric surgery THOR Thoracic surgery KPRO Knee prosthesis
HTP Heart transplant THYR Thyroid and/or parathyroid surgery PACE Pacemaker surgery
HYST Abdominal hysterectomy VHYS Vaginal hysterectomy PVBY Peripheral vascular bypass surgery
KTP Kidney transplant XLAP Exploratory Laparotomy RFUSN Refusion of spine
OTH Other NHSN operative procedures not included VSHN Ventricular shunt
in these categories
Specific Sites of an Organ/Space SSI

Code Site Code Site
BONE Osteomyelitis LUNG Other infections of the respiratory tract
BRST Breast abscess or mastitis MED Mediastinitis
CARD Myocarditis or pericarditis MEN Meningitis or ventriculitis
DISC Disc space ORAL Oral cavity (mouth, tongue, or gums)
EAR Ear, mastoid OREP Other infections of the male or female reproductive tract
EMET Endometritis PJI Periprosthetic Joint Infection
ENDO Endocarditis SA Spinal abscess without meningitis
EYE Eye, other than conjunctivitis SINU Sinusitis
GIT GI tract UR Upper respiratory tract
HEP Hepatitis USI Urinary System Infection
IAB Intraabdominal, not specified VASC Arterial or venous infection
IC Intracranial brain abscess or dura VCUF Vaginal cuff
JNT Joint or bursa
(Criteria for these sites can be found in the NHSN Help system [must be logged in to NHSN] or the Surveillance Definitions for Specific Types of Infections chapter).
9
GENERAL PRODUCT SELECTION
10
General Product Selection
Quick Reference Guide General Product Selection
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement, antibiotics, and compression therapy as appropriate.
Microbial Stalled or Exudate Needs Granulation Needs Needs Compression,

Contamination Delayed Healing Management or Dermal Epidermal Coverage as Clinically Indicated
(Bioburden) Replacement (0.5-above 1.2 ABPI Index)
V.A.C. VERAFLO Therapy with V.A.C. VERAFLO or V.A.C. VERAFLO CLEANSE Dressings PAGES 27-28
V.A.C. Therapy with V.A.C. GRANUFOAM and/or V.A.C. WHITEFOAM Dressings PAGES 22-26
SNAP Therapy System1

PAGE 30
PROMOGRAN Matrix Wound

PROMOGRAN PRISMA Dressing or PROMOGRAN PROMOGRAN Matrix Wound Dressing or PROMOGRAN
Matrix1,2 PAGES 35-36 PRISMA Matrix1,2 PRISMA Matrix1,2 PAGES 35-36
PAGES 35-36
SILVERCEL NON-ADHERENT or SILVERCEL Antimicrobial Alginate Dressing1,2 PAGES 37-38
Minimizing dressing adherence to the wound

ADAPTIC TOUCH Non-Adhering Silicone Dressing or ADAPTIC Non-Adhering Dressing1,2 PAGE 32
DYNA-FLEX Multi-layer
Secondary Dressing Primary or Secondary Dressings Compression System (to help
TIELLE Family1 PAGES 39-41 TIELLE Family1 PAGES 39-41 reduce the effects of venous
insufficiency) PAGE 33
NU-DERM Hydrocolloid CELLUTOME Epidermal

Wound Dressing2 Harvesting System2
PAGE 34 PAGE 45
PREVENA Incision
Management System
(for closed incisions only) GRAFTJACKET Matrices2 PAGE 42
PAGE 44
1. Cleared for use with compression therapy 2. Needs secondary dressing (i.e., TIELLE Family)
11
Venous Leg Ulcers
Venous Leg Ulcers
Healed or Partial Thickness Full Thickness

Skin at Risk
12
Venous Leg Ulcers
Venous Leg Ulcers
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement, antibiotics, and compression therapy as appropriate.


PAGE 30

PROMOGRAN PRISMA Dressing or PROMOGRAN PROMOGRAN Matrix Wound Dressing or
Matrix1,2 PAGES 35-36 PRISMA Matrix1,2 PROMOGRAN PRISMA Matrix1,2 PAGES 35-36
PAGES 35-36
DYNA-FLEX Multi-layer
SILVERCEL NON-ADHERENT or SILVERCEL Antimicrobial Alginate Dressing1,2 PAGES 37-38 Compression System
PAGE 33

ADAPTIC TOUCH Non-Adhering Silicone Dressing or ADAPTIC Non-Adhering Dressing1,2* PAGE 32
Secondary Dressing Primary or Secondary Dressings TIELLE Family1 PAGES 39-41

TIELLE Family1 PAGES 39-41
CELLUTOME Epidermal
NU-DERM Hydrocolloid Wound Harvesting System2
Dressing2 PAGE 34 PAGE 45
GRAFTJACKET Matrices2 PAGE 42
13
Diabetic Foot Ulcers
What is the grade of the Diabetic Foot Ulcer as per the Wagner Grading System?
Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Grade 5

Intact Skin Superficial ulcer Ulcers extend Deep ulcer with Gangrene of Midfoot
of skin or into tendon, osteomyelitis toes or forefoot or hindfoot
subcutaneous bone, or capsule or abscess gangrene
tissue
14

Grades represent the Wagner Grading System appropriate for each product.
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics.

V.A.C. Therapy with V.A.C. GRANUFOAM and/or V.A.C. WHITEFOAM Dressings PAGES 22-26 Not Applicable

PAGE 30
PROMOGRAN PRISMA PROMOGRAN Matrix Wound

Matrix1,2 PAGES 35-36 Dressing or PROMOGRAN PROMOGRAN Matrix Wound Dressing or
PRISMA Matrix1,2 PROMOGRAN PRISMA Matrix1,2 PAGES 35-36
PAGES 35-36

Secondary Dressing Primary or Secondary Dressings

TIELLE Family1 PAGES 39-41 TIELLE Family1 PAGES 39-41

PAGE 34 PAGE 45
15
Pressure Ulcers
Pressure Ulcers
What is the grade of the Pressure Ulcer on the NPUAP Classification System?
Stage I Stage II Stage III Stage IV Unstageable Suspected Deep

Non-blanchable Partial thickness Full thickness Full thickness Full thickness skin Tissue Injury
erythema skin loss tissue loss or tissue loss Depth unknown
depth unknown
16
Pressure Ulcers
REPLACE
Pressure Ulcers IMAGE

Not Applicable

PAGES 35-36



PAGE 34 PAGE 45
17
Non-Healing Surgical Wounds
Superficial Deep Incisional Organ/Space

Incisional
18

V.A.C. Therapy with V.A.C. GRANUFOAM and/or V.A.C. WHITEFOAM Dressings PAGES 22-26 Not Applicable

PAGES 35-36



PAGE 34 PAGE 45
PREVENA Incision
Management System GRAFTJACKET Matrices2 PAGE 42
(for closed incisions only)
PAGE 44
19
Arterial Ulcers
Arterial Ulcers
Dry, Stable Eschar Partial thickness Full-thickness
20
Arterial Ulcers
Arterial Ulcers
When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics and/or thorough vascular assessment with appropriate intervention.


PROMOGRAN PRISMA Dressing or PROMOGRAN PROMOGRAN Matrix Wound Dressing or
Matrix1,2 PAGES 35-36 PRISMA Matrix1,2 PROMOGRAN PRISMA Matrix1,2 PAGES 35-36
PAGES 35-36
Not Applicable


CELLUTOME Epidermal
Harvesting System2
PAGE 45
21
Negative Pressure Wound Therapy
V.A.C. Therapy with V.A.C. GRANUFOAM Dressing

What is it?
V.A.C. Therapy promotes wound healing through well-established mechanisms of action
Macrostrain: Microstrain:1-4
Decreases wound margins Promotes granulation tissue formation
Removes exudate and perfusion by means of:
Reduces edema Cell proliferation
Removes infectious material Fibroblast migration
SENSAT.R.A.C. Technology with EASYCLEAR Purge Technology

Only KCI V.A.C. Therapy provides patented SENSAT.R.A.C. Technology, a real-time
pressure feedback system that adjusts pump output, compensating for wound distance,
wound position, exudate characteristics, and patient movement. EASYCLEAR Purge
Technology facilitates exudate removal and helps increase accuracy of blockage alarm.
Why use V.A.C. Therapy with V.A.C. GRANUFOAM Dressings in a wide

variety of wounds?
V.A.C. Therapy promotes granulation tissue formation while providing a closed, moist
wound healing environment.
V.A.C. GRANUFOAM Dressing can be easily trimmed to fit the contours of deep or
irregularly shaped wounds and are available in a variety of configurations for bridging
techniques and offloading when treating multiple wounds.
22
V.A.C. Therapy with V.A.C. GRANUFOAM SILVER Dressing

What is it?
V.A.C. GRANUFOAM SILVER Dressing is an advanced wound dressing to assist granulation
tissue formation and enhance exudate removal with the effective bacterial barrier
properties of silver.
Why use V.A.C. Therapy for chronic, critically colonized, or infected wounds*?
V.A.C. Therapy promotes granulation tissue formation while providing a closed, moist wound
healing environment.
V.A.C. GRANUFOAM SILVER Dressing:
The only silver dressing that allows the V.A.C. GRANUFOAM Dressing pores to come in
direct contact with the wound, eliminating the need for additional silver dressing layers
that may inhibit negative pressure and granulation.
Micro-bonded metallic silver is uniformly distributed throughout the dressing,
providing silver even after sizing.
Easy-to-use: A single application of V.A.C. GRANUFOAM SILVER Dressing eliminates
the need for adjunct silver dressings.
Effective protection: Based on in-vitro microbial testing, provides an effective barrier to
bacterial penetration. The protective silver ion reduces aerobic, gram-negative
and gram-positive bacteria, and may help reduce infections in wounds.
* When used in conjunction with good clinical practice, such as appropriate use of sharp debridement and/or antibiotics.
23
V.A.C. Therapy with V.A.C. SIMPLACE EX Dressing/SIMPLACE Dressing

with 3M Tegaderm Drape
What is it?
V.A.C. SIMPLACE Dressings have been specifically designed to simplify the V.A.C. Therapy
dressing placement process.
Why use V.A.C. Therapy in difficult anatomical areas?

Designed to simplify the V.A.C. Therapy dressing placement process
Spiral-cut foam is simple to size
No scissors necessary
V.A.C. SIMPLACE EX Dressing: Precut V.A.C. Strips provides easier application and
fewer steps for bridging
V.A.C. SIMPLACE EX Dressing is supplied with 2 V.A.C. GRANUFOAM Spiral Dressings,
2 strips of V.A.C. Drape, 1 SENSAT.R.A.C. Pad with connector, and 1 disposable ruler
V
.A.C. SIMPLACE Small Dressing with 3M Tegaderm Drape is supplied with 2 V.A.C.
GRANUFOAM Spiral Dressings, 2 sheets of 3M Tegaderm Drape, 1 SENSAT.R.A.C.
Pad with connector, and 1 disposable ruler
24
V.A.C. Therapy with V.A.C. GRANUFOAM Bridge/Bridge XG Dressing

What is it?
V.A.C. GRANUFOAM Bridge Dressing Family is ideal for use with wounds in pressure
sensitive areas that require bridging.
V.A.C. GRANUFOAM Bridge Dressing includes components designed to simplify dressing
application including:
A wicking layer that helps intact skin stay dry
Integrated bridge allows for SENSAT.R.A.C. Pad placement away from wound site
Why use V.A.C. Therapy in areas of pressure (plantar sacrum, etc.) wounds?
V.A.C. Therapy promotes granulation tissue formation while providing a closed, moist wound
healing environment.
The V.A.C. GRANUFOAM Bridge Dressing has been specifically designed to place the
SENSAT.R.A.C. Pad away from the wound site. This makes it ideal for use in diabetic foot
wounds requiring off-loading therapy or VLUs requiring compression therapy. This dressing
helps improve mobility, allowing patients to resume activities of daily living, and facilitates
patient transition to a non-acute care setting with an off-loading boot and V.A.C. Therapy.
The V.A.C. GRANUFOAM Bridge Dressing is supplied with 1 V.A.C. GRANUFOAM Dressing
(6 x 17 x 1.9cm), 1 (67cm) with integrated SENSAT.R.A.C. Pad, 1 sheet of perforated V.A.C.
Drape with pre-cut hole, and 1 disposable ruler.
V
.A.C. GRANUFOAM Bridge XG Dressing is supplied with 2 V.A.C. GRANUFOAM Spiral
Dressings, 1 V.A.C. GRANUFOAM Bridge Dressing (67cm) with integrated SENSAT.R.A.C. Pad, 1
sheet of V.A.C. Drape, 1 sheet of perforated V.A.C. Drape with pre-cut hole, and 1 disposable ruler.
25
V.A.C. Therapy with V.A.C. WHITEFOAM Dressing

What is it?
V.A.C. WHITEFOAM Dressings are a versatile, polyvinyl alcohol dressing used
for tunnels and undermining, in situations where hypergranulation responses are
likely and to bolster split thickness skin grafts
Why use V.A.C. WHITEFOAM Dressings in a wide variety of wounds?

V.A.C. Therapy promotes granulation tissue formation while providing a closed,
moist wound healing environment.
V.A.C. WHITEFOAM Dressings have:
Higher tensile strength facilitating removal from tunnels and undermining
Opening cell non-reticulated properties to help minimize in growth of granulation tissue
for a more comfortable dressing change
Less adherent material than V.A.C. GRANUFOAM Dressing for use as a bolster for
skin grafts is pre-moistened with sterile water
26
V.A.C. VERAFLO Instillation Therapy

What is it?
V.A.C. VERAFLO Instillation Therapy combines the benefits of V.A.C. Therapy with automated
delivery, soak and removal of topical wound solution.
V.A.C. VERAFLO Instillation Therapy can help:

CLEANSE the wound with instillation of topical wound cleaners in a consistent, controlled manner
Treat the wound with instillation of appropriate topical antimicrobial and antiseptic solutions and the
removal of infectious material
Heal the wound and prepare for primary or secondary closure
Why use V.A.C. VERAFLO Instillation Therapy?

V.A.C. VERAFLO Instillation Therapy combines the benefits of V.A.C. Therapy with
automated delivery, soak and removal of topical wound solution.
V.A.C. VERAFLO Instillation Therapy provides:
Volumetric Delivery
With a pump for automated delivery of topical wound solutions that can easily be
programmed to meet wound requirements
Fill Assist
Helps determine the correct solution volume to instill
Dressing Soak
Instills topical wound solution into the wound for easier dressing removal and increased
patient comfort at dressing change
A physician panel recommends to use V.A.C. VERAFLO Therapy5 when:

Patient has two or more clinically relevant co-morbidities OR
Wound is complex OR
Patient has an American Society of Anesthesiologists Physical Status Classification6 of 2
27
V.A.C. VERAFLO Instillation Therapy

How to select V.A.C. VERAFLO Instillation Therapy setting considerations?5
Solution:
If patient has received an aggressive operative debridement with little to no remaining infectious material,
slough or wound debris; consider normal saline
If patient has received an extensive debridement and concerns of inadequate reduction in wound bioburden
remains or normal saline has not achieved desired results, consider compatible topical wound solutions (see
Solution Guide (DSL#14-0627.US (Rev. 10/14) LIT#29-A-212, Visit VeraFlo.com for document)
Soak Time:
Consider 10- 20 minutes*
V.A.C. Therapy Time:
Consider 2-4 hours*
How to determine if V.A.C. VERAFLO Instillation Therapy can be considered successful?5
Sufficient robust granulation tissue is present in the wound bed such that primary closure can be achieved OR
Wound has reached a stage such that it can be covered with a flap or graft OR
Conventional NPWT can be initiated to further reduce the wound area at patient discharge
*Soak time is affected by solution selection. Consult solution manufacturer for recommended time. Both soak time and V.A.C. Therapy time are affected by wound size
and anatomic location. Wounds with a greater leak potential should have shorter soak times and longer V.A.C. Therapy times.
28
V.A.C. Therapy Units and Canisters V.A.C. GRANUFOAM and V.A.C. SIMPLACE Dressings with SENSAT.R.A.C. Technology
Part Number Description Part Number Description
ULTDEV01/US V.A.C.ULTA Therapy Unit, United States M8275042/10 V.A.C. GRANUFOAM Bridge Dressing, 10-pack
340000 ACTIV.A.C. Therapy Unit, United States M8275042/5 V.A.C. GRANUFOAM Bridge Dressing, 5-pack
M8275044/5 V.A.C. GRANUFOAM Bridge XG Dressing, 5-pack
M8275063/10.S INFOV.A.C. 500ml Canister w/Gel, 10-pack
M8275051/10 V.A.C. GRANUFOAM Small Dressing, 10-pack
M8275063/5.S INFOV.A.C. 500ml Canister w/Gel, 5-pack
M8275051/5 V.A.C. GRANUFOAM Small Dressing, 5-pack
M8275071/10.S INFOV.A.C. 500ml Canister w/o Gel, 10-pack
M8275052/10 V.A.C. GRANUFOAM Medium Dressing, 10-pack
M8275071/5.S INFOV.A.C. 500ml Canister w/o Gel, 5-pack M8275052/5 V.A.C. GRANUFOAM Medium Dressing, 5-pack
M8275093/5.S INFOV.A.C. 1000ml Canister w/Gel, 5-pack M8275053/10 V.A.C. GRANUFOAM Large Dressing, 10-pack
M8275058/10 ACTIV.A.C. Canister w/Gel-10, 300ml M8275053/5 V.A.C. GRANUFOAM Large Dressing, 5-pack
M8275058/5 ACTIV.A.C. Canister w/Gel-5, 300ml M8275065/5 V.A.C. GRANUFOAM X-Large Dressing, 5-pack
M8275046/5 V.A.C. SIMPLACE EX Small Dressing, 5-pack
V.A.C. WHITEFOAM Dressings with SENSAT.R.A.C. Technology
M8275045/5 V.A.C. SIMPLACE EX Medium Dressing, 5-pack
Part Number Description M8275041/10 V.A.C. SIMPLACE Small Dressing
M6275033/10 V.A.C. WHITEFOAM Small Dressing, Foam Only, 10-pack M8275041/5 V.A.C. SIMPLACE Small Dressing
M6275034/10 V.A.C. WHITEFOAM Large Dressing, Foam Only, 10-pack M8275040/10 V.A.C. SIMPLACE Medium Dressing
M8275067/10 V.A.C. WHITEFOAM Large Dressing, 10-pack M8275040/5 V.A.C. SIMPLACE Medium Dressing
M8275067/5 V.A.C. WHITEFOAM Large Dressing, 5-pack
M8275068/10 V.A.C. WHITEFOAM Small Dressing, 10-pack
V.A.C. VERAFLO Therapy Dressings and Supplies
M8275068/5 V.A.C. WHITEFOAM Small Dressing, 5-pack
Part Number Description
V.A.C. GRANUFOAM SILVER Dressings ULTVFL05SM V.A.C. VERAFLO Dressing, 5-pack, Small
Part Number Description ULTVFL05MD V.A.C. VERAFLO Dressing, 5-pack, Medium
M8275098/5 V.A.C. GRANUFOAM SILVER Dressing, 5-pack, Small ULTVCL05MD V.A.C. VERAFLO CLEANSE Dressing, 5-pack, Medium
M8275098/10 V.A.C. GRANUFOAM SILVER Dressing, 10-pack, Small ULTLNK0500 V.A.C. VERALINK Cassette, 5-pack
M8275096/5 V.A.C. GRANUFOAM SILVER Dressing, 5-pack, Medium ULTDUO0500 V.A.C. VERAT.R.A.C. DUO Tube Set, 5-pack
M8275096/10 V.A.C. GRANUFOAM SILVER Dressing, 10-pack, Medium References for pages 22-28
M8275099/5 V.A.C. GRANUFOAM SILVER Dressing, 5-pack, Large 1. McNulty A, Spranger I, Courage J, et al. The consistent delivery of negative pressure to wounds using
M8275099/10 V.A.C. GRANUFOAM SILVER Dressing, 10-pack, Large reticulated, open cell foam and regulated pressure feedback. Wounds. 2010 May;22(5):114-120.
2. S axena V, Hwang C-W, Huang S, et al. Vacuum-assisted closure: microdeformations of wounds and
cell proliferation. Plastic and Reconstructive Surgery. 2004 Oct;114(5):1086-1096; discussion 1097-8.
3. M cNulty AK, Schmidt M, Feeley T, Kieswetter K. et al. Effects of negative pressure wound therapy
on fibroblast viability, chemotactic signaling, and proliferation in a provisional wound (fibrin) matrix.
Wound Repair Regen. 2007 November 1;15(6):838-46.
4. McNulty AK, Schmidt M, Feeley T, et al. Effects of negative pressure wound therapy on cellular
energetics in fibroblasts grown in a provisional wound (fibrin) matrix. Wound Repair Regen. 2009
March 1;17(3):192-9.
5. Kim PJ, Attinger CE, Crist BD, et al. Negative pressure wound therapy with instillation: review of
evidence and recommendations Wounds. 2015;27(12):Suppl 1-20.
6. Fitz-Henry J. The ASA classification and peri-operative risk. Ann R Coll Surg Engl. 2011;93:185-87.
29
Disposable NPWT
SNAP Therapy System

What is it?
The SNAP Therapy System is a disposable, off-the-shelf NPWT solution that combines
the simplicity of advanced dressings with the benefits of negative pressure therapy.
Why use SNAP Therapy for DFU and VLU wounds?

Ideal for small to medium DFUs and VLUs with low amounts of exudate
Small, silent, lightweight system designed for ambulatory or elderly patients
Medicare reimbursed in Wound Care Clinics (97607/8)
SNAP Therapy System

SNPA125 SNAP Therapy Cartridge, -125mmHg, 60ml
SKTF10X10 SNAP Advanced Dressing Kit (Foam), 10cm x 10cm
SKTF15X15 SNAP Advanced Dressing Kit (Foam), 15cm x 15cm
BKTF14X11 SNAP Bridge Dressing Kit (Foam), 14cm x 11cm
BKTF14X11S SNAP Bridge Dressing Kit (Foam) with SecurRing Hydrocolloid, 14cm x 11cm
SRNG10 SNAP SecurRing Hydrocollloid, 2 diameter
STPAS SNAP Therapy Strap, Small, 18
STPAM SNAP Therapy Strap, Medium, 21
STPAL SNAP Therapy Strap, Large, 24
30
Advanced Wound Dressings
Acelity Products: Advanced Wound Dressings
Promote Granulation Minimize Adherence

PROMOGRAN Matrix Wound Dressing and ADAPTIC Non-Adhering Dressing and
PROMOGRAN PRISMA Matrix ADAPTIC TOUCH Non-Adhering Silicone Dressing
To help promote a moist wound environment To help protect from adherence and minimize
conducive to granulation tissue formation, trauma and pain on dressing removal.
epithelialization, and rapid wound healing.
Antimicrobial Manage Exudate

SILVERCEL Antimicrobial Alginate and TIELLE Hydropolymer Adhesive Dressings
SILVERCEL Non-Adherent Dressings To help provide a comfortable and effective moist
To help manage bacterial contamination and wound environment for all types of wounds and/or
infection, while also dealing with the secondary protect the wound from external contamination.
symptoms of exudate and pain.
Compression NU-DERM Hydrocolloid Wound Dressings

DYNA-FLEX Multi-Layer Compression System To help maintain a moist wound environment on non to
To help reduce the effects of venous insufficiency moderately exuding wounds. There are three variants in
DYNA-FLEX Multi-Layer Compression System the range, coming in a variety of shapes and sizes.
provides proven sustained compression.
Please refer to the full Instructions for Use in the packaging insert.
31
ADAPTIC Non-Adhering Dressing and ADAPTIC TOUCH Non-Adhering Silicone

Dressing
What are they?
ADAPTIC Non-Adhering Dressing is a primary wound contact layer made of knitted cellulose acetate mesh,
impregnated with a petrolatum emulsion.
ADAPTIC TOUCH Non-Adhering Silicone Dressing is a flexible, open-mesh primary wound contact layer comprised of
cellulose acetate coated with a soft tack silicone, designed to facilitate fluid transfer to secondary dressing and minimize
adherence and pain at dressing change. It may be used in conjunction with Negative Pressure Wound Therapy for the
protection of fragile wound structures.
ADAPTIC Non-Adhering Dressings ADAPTIC TOUCH Non-Adhering Silicone Dressings

Item Code Size Each carton/box HCPCS code Item Code Size Each carton/box HCPCS code
2012 3 x 3 50 EA/CT - 12 CT/BX A6222 500501 2 x 3 10 EA/CT - 5CT/BX A6206
2013 3 x 8 36 EA/CT - 6 CT/BX A6223 500502 3 x 4 1/4 10 EA/CT - 5CT/BX A6206
2014 3 x 16 36 EA/CT - 6 CT/BX A6223 500503 5 x 6 10 EA/CT - 5CT/BX A6207
2015 3 x 8 24 EA/CT - 6 CT/BX A6223 500504 8 x 12 3/4 5 EA/bx A6208
2018 3 x 60 Roll 10 rolls/BX A6266
2019 5 x 9 Sheet 12 EA/CT - 6 CT/BX A6223
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service#: 1-800-275-4524
Why use ADAPTIC TOUCH Dressings for wounds?

Soft tack silicone assists dressing application, conformability and atraumatic removal1,2
Advanced mesh design means minimized risk of exudate pooling and secondary dressing adherence
to the wound1,2
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service #: 1-800-275-4524
References:
1. Stephens S, Brosnan P, Mistry P, et al. Evaluation of a non-adhering silicone wound contact dressing with optimised design for the management of dry to heavily
exuding wounds (in-vitro/vivo). Poster, Wounds UK 2010.
2. Stephens S, Mishey P, Addison D, et al. Evaluation of the properties of a non-adhering silicone primary wound contact layer (in vitro). Poster, Wounds UK 2010.
32
DYNA-FLEX Multi-Layer Compression System

What is it?
DYNA-FLEX Multi-Layer Compression System provides proven sustained compression to reduce the effects
of venous insufficiency.
First layer: Made of cool, breathable cotton and foam
Second layer: Compression bandage uses an innovative, patented visual cue to aid proper application
Third layer: Cohesive compression bandage helps prevents slippage and increases compliance
DYNA-FLEX Multi-Layer Compression System

Item code Each carton/box HCPCS code
7025 8 units/CS A6223
A6421 1st Layer
A6430 2nd Layer
A6438 3rd Layer
Why use DYNA-FLEX Multi-Layer Compression System for wounds?

DYNA-FLEX Multi-Layer Compression System provides sustained compression for up to 7 days
at both the ankle and below the knee, when used according to package insert directions. Each
component has been carefully engineered to provide an effective solution ideal for use in all settings.
Foam backing provides strength for added stretching and conformability
Absorbs exudate
Comfortable for the patient
Helps protect the patient from pressure points
The bandage is printed with a rectangular pattern that turns into a square when correct level of
stretch is achieved to assist in achieving reproducible pressures from one practitioner to another
Reduces slippage
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert.
33
NU-DERM Hydrocolloid Wound Dressings

What is it?
NU-DERM Hydrocolloid Wound Dressings are designed to help maintain a moist wound
environment on non-exuding to moderately exuding wounds. There are three variants in the range,
coming in a variety of shapes and sizes.
NU-DERM Hydrocolloid Thin NU-DERM Hydrocolloid Border

Item code Size Each tray/CAse HCPCS code Item code Size Each tray/CAse HCPCS code
HCT101 4 x 4 10 EA/tray 10 trays/CA A6234 HCB102 2 x 2 20 EA/tray 5 trays/CA A6237
HCB204 4 x 4 10 EA/tray 16 trays/CA A6237
NU-DERM Hydrocolloid Standard HCB106 6 x 6 5 EA/tray 4 trays/CA A6238
HCF204 4 x 4 5 EA/tray 10 trays/CA A6237
HCF208 8 x 8 5 EA/tray 4 trays/CA A6236 NU-DERM Hydrocolloid Border Sacrum
HCS100 6 x 7 5 EA/tray 4 trays/CA A6238
Why use NU-DERM Hydrocolloid Dressings for wounds?

NU-DERM Hydrocolloid Dressings help maintain a moist wound healing environment
encouraging autolytic debridement, thus enabling granulation to proceed under optimum
conditions
Designed to protect low risk wounds against outside bacterial contamination
All NU-DERM Hydrocolloid Dressings are waterproof and can remain in place during
showering
34
PROMOGRAN Matrix Wound Dressing and PROMOGRAN PRISMA Matrix Family

What are they?
PROMOGRAN Matrix Wound Dressing is comprised of a sterile, freeze-dried composite of 45% oxidized
regenerated cellulose (ORC) and 55% collagen.
PROMOGRAN Matrix Wound Dressing
HCPCS code SKU Size Each/UOM UOM packaged
A6021 PG004 4.34sq. in Hexagon 40 10 EA/CT 4 CT/BX
A6022 PG019 19.1sq. in Hexagon 40 10 EA/CT 4 CT/BX
PROMOGRAN Matrix
Wound Dressing
composed of
55% Collagen
45% ORC
PROMOGRAN PRISMA Matrix comprised of a sterile, freeze-dried composite of 44% oxidized
regenerated cellulose (ORC), 55% collagen and 1% silver-ORC. Silver-ORC contains 25% w/w ionically
bound silver, a well-known antimicrobial agent.
PROMOGRAN PRISMA
Matrix composed of
55% Collagen PROMOGRAN PRISMA Matrix
45% ORC
1% Silver ORC HCPCS code SKU Size Each/UOM UOM packaged
A6021 MA028 4.34sq. in Hexagon 40 10 EA/CT 4 CT/BX
A6022 MA123 19.1sq. in Hexagon 40 10 EA/CT 4 CT/BX
35
Why use PROMOGRAN Matrix Wound Dressing and PROMOGRAN PRISMA Matrix
To help promote an optimal wound healing environment. This environment is conducive to
granulation tissue formation, epithelization and rapid wound healing.
They are supported by a large body of clinical evidence, including 10 published RCTs and more than
100 supporting publications.1-3
They have been demonstrated to achieve superior results in clinical practice1-5
Significant reduction in wound area. A 12-week RCT involving VLU patients (n=73) found that
wounds in the PROMOGRAN Matrix Wound Dressing group experienced a significantly greater
reduction in wound areas compared to Control (54.4% vs. 36.5%, p<0.0001)3
PROMOGRAN PRISMA Matrix contains ionic silver (silver - ORC), providing antimicrobial protection
against bacteria and infection.6
In clinical practice PROMOGRAN PRISMA Matrix has been demonstrated to protect against
infection and promote healing in DFUs.5
In the presence of exudate PROMOGRAN Matrix Wound Dressing and PROMOGRAN PRISMA
Matrix, transform into a soft, conformable, biodegradable gel, which does not have to be removed
from the wound.
The dressings can be cut with sterile scissors to fit the wound shape, or it can be pre-moistened to
form a gel and molded to fit the wound.
References:
1. Lazaro-Martinez J L, Garcia-Morales E, Beneit-Montesinos JV, et al. Randomized comparative trial of a collagen/oxidized regenerated cellulose dressing in the treatment of
neuropathic diabetic foot ulcers. F.R. Circ. Esp. 2007, 82(1), 27-31.
2. Veves A, Sheehan P, Pham H. A Randomized, Controlled Trial of Promogran (a Collagen Oxidized Regenerated Cellulose Dressing) vs. Standard Treatment in the Management of
Diabetic Foot Ulcers. Arch. Surg 2002, vol. 137:822-8274.
3. Vin F, Teot L, Meaume S. The healing properties of Promogran in venous leg ulcers. J. Wound Care 2002; 11(9):335-415.
4. Lanzara S, Zambau P. A pilot randomized trial to determine the effects of a new active dressing on wound healing of venous leg ulcers. Presentation EWMA 2008.
5. Gottrup F, Cullen B, Karlsmerk T, et al. Randomized controlled trial on collagen/oxidized regenerated cellulose/silver treatment. Wound Rep Reg 2013, 21:1-10.
6. Cullen B, Boyle C, Rennison T, et al. ORC/Collagen Matrix containing silver controls bacterial bioburden while retaining dermal cell viability. Poster, SAWC 2006.
7. Simmons R, Gibson M, Cullen B, et al. Effect of collagen ORC silver on bacterial proteases. Poster, CAWC 2013.
36
SILVERCEL Antimicrobial Alginate Dressing

What is it?
SILVERCEL Antimicrobial Alginate Dressing is a sterile, non-woven pad composed of high G (guluronic
acid) alginate, carboxymethylcellulose (CMC) and silver coated nylon fibers.
The unique composition of the dressing manages exudate in moderate to heavily exuding wounds,
promoting a favorable environment for effective wound management
SILVERCEL Antimicrobial Alginate Dressing provides a sustained release of silver ions within the
dressing for up to 7 days, allowing for an effective antimicrobial protection for the entire wear time,
depending on the level of exudate.1
SILVERCEL Antimicrobial Alginate Dressing is effective against more than 150 wound pathogens1
Indicated for acute and chronic wounds. Please refer to the full Instructions for Use in the packaging insert. Customer Service #: 1-800-275-4524.
1. Teot L, Maggio G, Barrett S. The management of wounds using SILVERCEL Hydro-Alginate. Wounds UK Supplement. 2005.1(2)
SILVERCEL Antimicrobial Alginate Dressing

Item code Size Each carton/box HCPCS code
800202 2 x 2 10 EA/CT 5 CT/BX A6196
800404 4 1/4 x 4 1/4 10 EA/CT 5 CT/BX A6197
800408 4 x 8 10 EA/CT 5 CT/BX A6197
800112 1 x 12 5 EA/CT 5 CT/BX A6199
37
SILVERCEL NON-ADHERENT Antimicrobial Alginate Dressing

What is it?
SILVERCEL NON-ADHERENT Dressing is the next generation of Antimicrobial Dressing with the unique
feature of a Non-Adherent layer to maximize protection of the wound bed.
The unique feature of EASYLIFT Precision Film Technology designed for intact removal, helps minimize
the risk of adherence to the wound bed, fibers shedding and allows easy and pain-free removal.
SILVERCEL NON-ADHERENT Dressing

Item code Size Each carton/box HCPCS code
900112 1 x 12 5 EA/CT 5 CT/BX A6199
900202 2 x 2 10 EA/CT 5 CT/BX A6196
900404 4 1/4 x 4 1/4 10 EA/CT 5 CT/BX A6197
900408 4 x 8 5 EA/CT 5 CT/BX A6197
Why use SILVERCEL Antimicrobial Alginate Dressing and SILVERCEL

NON-ADHERENT Antimicrobial Alginate Dressing for wounds?
The unique composition: a mixture of alginate, carboxymethylcellulose (CMC), and silver coated nylon
fibers manages exudate effectively in infected or heavily colonized wounds1
SILVERCEL NON-ADHERENT The unique EASYLIFT Precision Film layer allows intact and pain free removal minimizing pain and
Antimicrobial Alginate Dressing
trauma at dressing change for your patients2
Help maintain a moist wound environment beneficial to wound healing
Effective against a broad spectrum of wound pathogens, thus reducing wound malodor3
References:
1. Bogdanets L, Berezina S, Kuznetsov A, et al. New silver alginate dressing in the treatment of infected venous ulcers. EWMA, Glasgow, 2007. Page 247.
SILVERCEL Antimicrobial

Alginate Dressing 2. Clark R, Stephens S, DelBono M, Snyder R. From lab to leg: the importance of correlating in-vitro and in vivo test systems to clinical practice. SAWC 2010.
3. Clark R, Stephens S, DelBono M. The evaluation of absorbent silver containing dressings in-vitro. CAWC 2009.
38
TIELLE Family
What is it?
The TIELLE Family consists of a range of hydropolymer foam dressings with LIQUALOCK Advanced
Absorption Technology. The TIELLE Family is designed to manage different levels of exudates across a
range of wound types, helping minimize maceration. They come in a wide selection of shapes and sizes
with or without an adhesive border.
TIELLE Non-Adhesive Hydropolymer Dressing

Cut-able polyurethane foam dressing for low to highly exuding wounds
In vitro it is able to retain fluid under pressure equivalent to that exerted by
compression bandaging (40mmHg) up to 7 days without leakage1
Comfortable to wear, can be easily adapted, cut to shape and secured using the
NEW most appropriate method for the patient, e.g. compression bandage
TIELLE Non-Adhesive has improved fluid handling capacity by 30% compared
to TIELLE Xtra/Max/S1
TIELLE Silicone Border Hydropolymer Adhesive Dressing

Soft silicone for gentle removal on fragile and sensitive skin
Through the unique combination of LIQUALOCK Technology and soft silicone adhesive,
TIELLE Silicone Border:
Helps maintain an optimal moist wound healing environment1,2
NEW Allows gentle removal2,3
References:
1. Stephens S. Macauley, N. Hill, C. DelBono, M, Parker, D. Poster, (In Vitro) Evaluation of the Performance of a Non-Adhesive Foam Dressing for the management of Wound Exudate. SAWC,
San Antonio April 2015.
2. Turton K, Parker D, Delbono M, Lane T. In vitro evaluations of the dual functionality of a new hydropolymer dressing with silicone for the management of exudate and atraumatic removal.
Wounds UK Harrogate 2015. Poster.
3. Turton K, Lane T, Parker, D, Delbono M, Di Palo S. In vitro evaluation of the atraumatic removal of a new hydropolymer dressing with silicone. Presented at Wound UK Harrogate 2015 Poster.
39
Why use the TIELLE Family Dressings for wounds?

T he TIELLE Family comes in a wide range of sizes, shapes, and absorbencies, allowing you to find
a dressing that suits your patients needs
The TIELLE Family contains LIQUALOCK Technology, which helps retain fluid to minimize leakage,
allowing moisture vapor to pass through the dressing, helping to provide an optimal moist wound
healing environment*
The hydropolymer layer expands and conforms to the wound bed
LIQUALOCK Technology ensures the fluid is locked away, minimizing the risk of leakage and maceration1
M anaging exudate better helps wounds heal faster and increases patient comfort
M inimize strike through
T he polyurethane backing is shower-proof, vapor permeable, and protects against external
environmental contamination**
H olds exudates even under pressure1
*TIELLE Dressing packing only has hydropolymer layer: TIELLE Lite includes an additional non-adherent wound contact layer.
**Adhesive border TIELLE Dressing variants only.
1. Mellor J and Boothman S. TIELLE hydropolymer dressings: wound responsive technology. Br J Community Nurse.
2003;8(11 Suppl): 14-7.
TIELLE Hydropolymer Dressings with LIQUALOCK Advanced Absorption Technology

Brand type Item Code Description Size Eaches/CArton/Box/CAse* HCPCS Cut-able
TIELLE Lite Hydropolymer Adhesive Dressing

LIQUALOCK Advanced Absorption Technology MTL300EN TIELLE Lite 7cm x 9cm 7cm x 9cm / 2 x 3 10ea per CT / 5CT per BX / 9BX per CS A6212 -
LIQUALOCK Advanced Absorption Technology

MTL301EN TIELLE Lite 11cm x 11cm

11cm x 11cm / 4 x 4 10ea per CT / 5CT per BX / 4BX per CS A6212 -
LIQUALOCK Advanced Absorption Technology MTL308 TIELLE Lite 8cm x 15cm 8cm x 15cm / 3 1/8" x 5 7/8" 10ea per CT / 5CT per BX / 5BX per CS A6213 -
LIQUALOCK Advanced Absorption Technology MTL309 TIELLE Lite 8cm x 20cm 8cm x 20cm / 3 1/8" x 7 7/8" 10ea per CT / 5CT per BX / 5BX per CS A6223 -
LIQUALOCK Advanced Absorption Technology MTL310 TIELLE Lite 10cm x 30cm 10cm x 30cm / 4 x 11 10ea per CT / 3CT per BX / 4BX per CS A6213 -
TIELLE Hydropolymer Adhesive Dressing

LIQUALOCK Advanced Absorption Technology MTL100EN TIELLE Dressing 7cm x 9cm 7cm x 9cm / 2 x 3 10ea per CT / 5CT per BX / 9BX per CS A6212 -

MTL101EN TIELLE Dressing 11cm x 11cm

LIQUALOCK Advanced Absorption Technology MTL102 TIELLE Dressing 15cm x 20cm 15cm x 20cm / 5 7/8" x 7 7/8" 5ea per CT / 5CT per BX / 5BX per CS A6213 -

MTL103 TIELLE Dressing 18cm x 18cm

*NOTE: The sell-able unit of measure for the TIELLE Dressings with LIQUALOCK Advanced Absorption Technology is in Boxes ONLY.

40
TIELLE Family
TIELLE Hydropolymer Dressings with LIQUALOCK Advanced Absorption Technology (Cont.)
Brand type Item Code Description Size Eaches/CArton/Box/CAse* HCPCS Cut-able
TIELLE Plus Hydropolymer Adhesive Dressing

LIQUALOCK Advanced Absorption Technology MTP501 TIELLE Plus 11cm x 11cm 11cm x 11cm / 4 x 4 10ea per CT / 5CT per BX / 4BX per CS A6212 -

MTP502 TIELLE Plus 15cm x 20cm

15cm x 20cm / 5 7/8" x 7 5ea per CT / 5CT per BX / 4BX per CS A6213 -
LIQUALOCK Advanced Absorption Technology MTP505 TIELLE Plus 15cm x 15cm 15cm x 15cm / 5 7/8" x 5 7/8" 10ea per CT / 5CT per BX / 2BX per CS A6213 -
TIELLE Max Non-Adhesive Hydropolymer Dressing
LIQUALOCK Advanced Absorption Technology MTP701 TIELLE Max 11cm x 11cm 11cm x 11cm / 4 x 4 10ea per CT / 5CT per BX / 8BX per CS A6210 &
LIQUALOCK Advanced Absorption Technology MTP702 TIELLE Max 15cm x 20cm 15cm x 20cm / 5 7/8" x 7 7/8" 5ea per CT / 5CT per BX / 5BX per CS A6210 &

MTP705 TIELLE Max 15cm x 15cm

15cm x 15cm / 5 7/8" x 5 7/8" 10ea per CT / 5CT per BX / 4BX per CS A6210 &
TIELLE Non-Adhesive Hydropolymer Dressing - NEW

LIQUALOCK Advanced Absorption Technology TLN0505EN TIELLE Non-Adhesive 5cm x 5cm 5cm x 5cm / 2" x 2" 10ea per CT / 5CT per BX / 16BX per CS A6209 &

TLN1010EN TIELLE Non-Adhesive 10cm x 10cm

10cm x 10cm / 4" x 4" 10ea per CT / 5CT per BX / 12BX per CS A6209 &


15cm x 15cm / 6" x 6" 10ea per CT / 5CT per BX / 4BX per CS A6210 &
LIQUALOCK Advanced Absorption Technology TLN1717EN TIELLE Non-Adhesive 17.5cm x 17.5cm 17.5cm x 17.5cm / 7" x 7" 5ea per CT / 5CT per BX / 8BX per CS A6211 &


21cm x 22cm / 8" x 8 5/8" 5ea per CT / 5CT per BX / 5BX per CS A6211 &
TIELLE Silicone Border - NEW

LIQUALOCK Advanced Absorption Technology TLSB0709EN TIELLE Silicone Border 7cm x 9cm 7cm x 9cm / 2" x 3 10ea per CT / 5CT per BX / 4BX per CS A6212 -

TLSB1010EN TIELLE Silicone Border 10cm x 10cm 10cm x 10cm / 4" x 4" 10ea per CT / 5CT per BX / 4BX per CS A6212 -
LIQUALOCK Advanced Absorption Technology TLSB1212EN TIELLE Silicone Border 12.5cm x 12.5cm 12.5cm x 12.5cm / 5" x 5" 10ea per CT / 5CT per BX / 4BX per CS A6213 -

TLSB1717EN TIELLE Silicone Border 17.5cm x 17.5cm

17.5cm x 17.5cm / 7" x 7" 5ea per CT / 5CT per BX / 4BX per CS A6214 -
LIQUALOCK Advanced Absorption Technology TLSB2122EN TIELLE Silicone Border 21cm x 22cm 21cm x 22cm / 8" x 8 5/8" 5ea per CT / 5CT per BX / 3BX per CS A6214 -
TIELLE Packing Hydropolymer Dressing

LIQUALOCK Advanced Absorption Technology MT2450 TIELLE Packing 9.5cm x 9.5cm 9.5cm x 9.5cm / 3 x 3 10ea per CT / 5CT per BX / 12BX per CS A6215 &
TIELLE Sacrum
LIQUALOCK Advanced Absorption Technology MTL104 TIELLE Sacrum 17.5cm x 17.5cm 17.5cm x 17.5cm / 7 x 7 5ea per CT / 5CT per BX / 3BX per CS A6213 -
TIELLE Plus Sacrum
LIQUALOCK Advanced Absorption Technology MTP506 TIELLE Plus Sacrum 15cm x 15cm 15cm x 15cm / 5 7/8" x 5 7/8" 10ea per CT / 5CT per BX / 2BX per CS A6254 -
TIELLE Plus Heel

LIQUALOCK Advanced Absorption Technology MTP508 TIELLE Plus Heel 20cm x 26.5cm 20cm x 26.5cm / 7 7/8 x 10 5ea per CT / 5CT per BX / 4BX per CS A6213 -
*NOTE: The sell-able unit of measure for the TIELLE Dressings with LIQUALOCK Advanced Absorption Technology is in Boxes ONLY.

41
Regenerative Tissue Matrix
GRAFTJACKET Regenerative Tissue Matrix (RTM) and GRAFTJACKET Xpress

Flowable Soft Tissue Scaffold (FSTS)
What is it?
GRAFTJACKET Regenerative Tissue Matrix for wounds provides a scaffold for the bodys repair or
replacement of damaged or inadequate integumental tissue, such as diabetic foot ulcers, venous leg
ulcers, pressure ulcers, or for other homologous uses of human integument.
GRAFTJACKET RTM is a thin, fenestrated acellular human dermal matrix designed for single
application
GRAFTJACKET Xpress FSTS is a micronized form of GRAFTJACKET RTM (processed acellular
human dermis)
GRAFTJACKET Xpress FSTS is a flowable, acellular soft tissue treatment for tunneling and
irregularly contoured wounds
GRAFTJACKET Regenerative Tissue Matrix
GJ44 GRAFTJACKET Regenerative Tissue Matrix, 4 x 4cm
GJ48 GRAFTJACKET Regenerative Tissue Matrix, 4 x 8cm
GJX GRAFTJACKET Xpress Flowable Soft Tissue Scaffold, 2cc
Why use for wounds needing dermal replacement?

GRAFTJACKET RTM:
Requires only one application, in most cases, and can be placed in the operating room or
outpatient setting
Provided in a thin sheet for conformability to the wound, maintaining surface area contact
when sutured or stapled in place
Fenestrated to allow for wound fluid to escape
GRAFTJACKET Xpress FSTS:
Conforms to the shape of the wound and fills deep tunneling and irregularly contoured wounds
Replaces damaged or missing dermal tissue with like tissue by supporting cellular repopulation
and revascularization by host tissue
42
Open Abdomen Management
ABTHERA Open Abdomen Negative Pressure Therapy

What is it?
ABTHERA Therapy is a temporary abdominal closure (TAC) system that helps surgeons take control early
when managing a challenging open abdomen, helping to achieve primary fascial closure.
ABTHERA Open Abdomen Negative Pressure Therapy
M8275026 ABTHERA SENSAT.R.A.C. OA Dressing, 5-pack. Compatible with V.A.C.ULTA and INFOV.A.C. Therapy Units
370605 ABTHERA OA Dressing (with interface pad), 5-pack. Compatible with ABTHERA Therapy Unit
370620 ABTHERA Canister, 20-pack. Compatible with ABTHERA Therapy Unit
370642 ABTHERA Tubing Set, 5-pack. Compatible with ABTHERA Therapy Unit
370500 ABTHERA Therapy Unit
Why use for open abdomen management?

ABTHERA Open Abdomen Negative Pressure Therapy:
- Actively removes fluid and helps reduce edema
- Provides medial tension which helps minimize fascial retraction and loss of domain1
- Provides separation between the abdominal wall and viscera, protecting abdominal contents
- Allows rapid access for re-entry and does not require sutures for placement
References:
1. Miller Pr, et al. Prospective evaluation of vacuum-assisted fascial closure after open abdomen: planned ventral hernia rate is substantially reduced. Ann Surg. 2004 May; 239(5):608-614.
43
Incision Management System
PREVENA Incision Management System

What is it?
The PREVENA Incision Management System is intended to manage the environment of surgical
incisions that continue to drain following sutured or stapled closure by maintaining a closed
environment and removing exudate via the application of negative pressure wound therapy.
PREVENA Incision Management System

PRE1001US PREVENA PEEL & PLACE Kit, 20cm
PRE1055US PREVENA PEEL & PLACE Dressing - 20cm, 5-pack
PRE1101US PREVENA PEEL & PLACE Kit, 13cm
PRE1155US PREVENA PEEL & PLACE Dressing - 13cm, 5-pack
PRE1095 PREVENA 45ml Canister, 5-pack
PRE2001US PREVENA CUSTOMIZABLE Kit
PRE2055US PREVENA CUSTOMIZABLE Dressing, 5-pack
PRE4001US PREVENA PLUS System Kit
AVAILABLE PRE4055US PREVENA PLUS CUSTOMIZABLE Dressing, 5-pack
JUNE, 2016 PRE4095 PREVENA PLUS Canister Kit, case of 5
PRE9090 PREVENA V.A.C. Connector, case of 10
Why use for incision management?

PREVENA Incision Management System:
Holds incision edges together
Protects incision site from external infectious sources
Removes fluids and infectious materials from the surgical site
Lightweight and portable
Available in two PREVENA PEEL & PLACE Dressing options
PEEL & PLACE Dressing - 13cm (for use on linear incisions up to 13cm)
PEEL & PLACE Dressing - 20cm (for use on linear incisions up to 20cm)
PREVENA CUSTOMIZABLE Dressing (for use on linear or non-linear incisions up to 90cm)
PREVENA PLUS CUSTOMIZABLE System (for use on linear and non-linear incisions up
to 90cm; with SENSAT.R.A.C. Technology and 150ml canister)
44
Epidermal Harvesting System
CELLUTOME Epidermal Harvesting System

What is it?
The CELLUTOME Epidermal Harvesting System is an innovative device that allows automated
creation and harvesting of patients own epidermal grafts that can easily be applied to a recipient
site for the first time in a wound care center.
CELLUTOME Epidermal Harvesting System

CT-KIT/US CELLUTOME Control Unit and CELLUTOME Vacuum Head
CT-CUSl CELLUTOME Control Unit Stand
CT-TFLM 3M Tegaderm Film, box of 100
CT-H25 CELLUTOME Harvester 2.5cm 5-pack
CT-H50 CELLUTOME Harvester 5 x 5cm 5-pack
CT-5XT.5 CELLUTOME Extension Strap 5-pack
500501 ADAPTIC TOUCH Non-Adhering Silicone Dressing 2 x 3, box of 50
Why use the CELLUTOME Epidermal Harvesting System for wounds?

Automated, precise and reproducible process
Fast harvesting epidermal graft procedure, takes on average 45 minutes
Can be performed by any suitably trained physician on your team
No Local Coverage Determination (LCD) limitations on epidermal grafting
Easily integrated into existing practice
45
Wound Glossary
Abrasion: S uperficial wound caused by the scraping away of the skin by mechanical means.
Abscess: Buildup of infected fluid/pus formed in tissue as a result of infection.
Alginate: A natural absorptive (hydrophilic) wound dressing manufactured from brown seaweed that gels upon contact with wound
exudate.
Bacterial contamination: Bacteria are present in the wound.
Blister: Collection of fluid below or within the epidermis caused by friction, burning, or other damage.
Cellulitis: Inflammation, redness, edema, and tenderness of the tissues indicative of infection.
Colonization: Bacteria are dividing and have invaded the wound surface.
Debridement: Removal of dead, damaged, or infected tissue from a wound to improve the healing potential of the remaining healthy
tissue.
Dehiscence: A surgical complication in which a wound ruptures along surgical suture.
Erythema: Superficial reddening of the skin, usually in patches, as a result of injury or irritation causing dilatation of the blood
capillaries.
Eschar: Thick, dry, dark or black falling away of dead skin, typically caused by a burn.
Exudate: Wound fluid or drainage, often increased in inflammation.
Full-thickness wound: Tissue destruction extending through the dermis and may involve subcutaneous tissue and structures such as
muscle, bone or supporting structures (e.g., tendons or ligaments).
Gangrene: Localized death and decomposition of body tissue, resulting from either obstructed circulation or bacterial infection.
Granulating: Healthy red tissue which is deposited during the repair process, and presents as pinkish/red colored moist tissue and
has newly formed collagen, elastin, and capillary networks.
Hydrocolloid dressing: A category of wound dressings engineered with materials, such as gelatin, pectin, and carboxymethylcellulose
that provide a moist healing environment and adhere to the skin around the wound.
Hydrogel: Wound treatment using water- or glycerin-based gels, impregnated gauzes or sheet dressings. Hydrogels maintain a moist
healing environment and absorb a minimal amount of wound exudate.
Infected wound: High bacteria counts (often measured as >105) with tissue damage to surrounding tissue.
Instillation therapy: Delivery to and removal of topical wound solutions to the wound bed.
46
Wound Glossary
Necrotic: Dead tissue that usually results from an inadequate local blood supply. Necrotic tissue is further classified as slough or
eschar and color ranges from red to brown, black, or purple.
Osteomyelitis: An infection in a bone. Infections can reach a bone by traveling through the bloodstream or spreading from nearby
tissue. Osteomyelitis can also begin in the bone itself if an injury exposes the bone to germs.
Partial-thickness: Wounds that extend through the epidermis and may go into, but not through the dermis.
Primary dressing: The wound care product that is placed directly on top of the wound itself.
Secondary dressing: Holds the primary dressing in place.
Skin graft: Removal of partial or full-thickness segment of epidermis and dermis from its blood supply and transplanting it to another
site to speed healing and reduce the risk of infection.
Slough: Yellow fibrinous tissue that accumulates in a wound thought to be associated with bacterial activity. Slough consists of fibrin,
pus and proteinaceous material.
Tunneling: An opening from the wound base that may extend into the subcutaneous tissue or to muscle. Tunneling may occur from
infection, in pressure ulcers from shear or pressure forces or may occur from the overfilling of a wound with excess dressing material
which exerts pressure on surrounding tissues.
Undermining: Overhanging skin edges at the margin of the wound.
47
For more information, call 800-275-4524 or visit acelity.com
NOTE: Specific indications, contraindications, warnings, precautions and safety information exist for all KCI and Systagenix products and therapies. Prior to the use of any
medical device, it is important for the provider to consult the treating physician and read and understand all Instructions for Use, including Safety Information, Dressing
Application Instructions, and Therapy Device Instructions. Rx only.
2016 KCI Licensing, Inc. and Systagenix Wound Management, Limited. All rights reserved. 3M and Tegaderm are trademarks of 3M Company. All other trademarks
designated within, unless otherwise noted, are proprietary to KCI Licensing, Inc. and Systagenix Wound Management, Limited, their respective affiliates and/or licensors.
DSL#16-0228.US.D (Rev. 4/16)

Wound Management Guide Digital

Hochgeladen von

Dokumentinformationen

Copyright

Verfügbare Formate

Dieses Dokument teilen

Dokument teilen oder einbetten

Freigabeoptionen

Stufen Sie dieses Dokument als nützlich ein?

Sind diese Inhalte unangemessen?

Copyright:

Verfügbare Formate

Wound Management Guide Digital

Hochgeladen von

Copyright:

Verfügbare Formate

2016 WOUND CARE

PRODUCT SELECTION GUIDE

Follow these three steps to use the guide:

General Product Selection

Diabetic Foot Ulcer Wagner Grading System

Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Grade 5

Pressure Ulcer Classification System*

Category/Stage II: Partial thickness

Category/Stage III: Full thickness skin loss

Category/Stage IV: Full thickness tissue loss

Additional Categories/Stages for the USA

Suspected Deep Tissue Injury depth unknown

Stage I: Stage II: Stage III:

Stage IV: Unstageable: Suspected Deep Tissue Injury:

Comprehensive Classification System for Chronic Venous Disorders (CEAP)

Classification Description Classification of Venous Ulcers Etiology*

Surgical Site Infection (SSI) Definitions

Surgical Site Infection Criteria

Comments There are two specific types of superficial incisional SSIs:

30-day Surveillance 90-day Surveillance

Specific Sites of an Organ/Space SSI

Quick Reference Guide General Product Selection

Microbial Stalled or Exudate Needs Granulation Needs Needs Compression,

SNAP Therapy System1

PROMOGRAN Matrix Wound

SILVERCEL NON-ADHERENT or SILVERCEL Antimicrobial Alginate Dressing1,2 PAGES 37-38

Minimizing dressing adherence to the wound

NU-DERM Hydrocolloid CELLUTOME Epidermal

Venous Leg Ulcers

Healed or Partial Thickness Full Thickness

Venous Leg Ulcers

Microbial Stalled or Exudate Needs Granulation Needs Needs Compression,

SNAP Therapy System1

PROMOGRAN Matrix Wound

Minimizing dressing adherence to the wound

Secondary Dressing Primary or Secondary Dressings TIELLE Family1 PAGES 39-41

GRAFTJACKET Matrices2 PAGE 42

Diabetic Foot Ulcers

Grade 0 Grade 1 Grade 2 Grade 3 Grade 4 Grade 5

Diabetic Foot Ulcers

Microbial Stalled or Exudate Needs Granulation Needs Needs Compression,

SNAP Therapy System1

PROMOGRAN PRISMA PROMOGRAN Matrix Wound

SILVERCEL NON-ADHERENT or SILVERCEL Antimicrobial Alginate Dressing1,2 PAGES 37-38

Minimizing dressing adherence to the wound

Secondary Dressing Primary or Secondary Dressings

NU-DERM Hydrocolloid CELLUTOME Epidermal

GRAFTJACKET Matrices2 PAGE 42

Stage I Stage II Stage III Stage IV Unstageable Suspected Deep

Microbial Stalled or Exudate Needs Granulation Needs Needs Compression,

PROMOGRAN PRISMA PROMOGRAN Matrix Wound

SILVERCEL NON-ADHERENT or SILVERCEL Antimicrobial Alginate Dressing1,2 PAGES 37-38

Minimizing dressing adherence to the wound

Secondary Dressing Primary or Secondary Dressings

NU-DERM Hydrocolloid CELLUTOME Epidermal

GRAFTJACKET Matrices2 PAGE 42

Non-Healing Surgical Wounds

Superficial Deep Incisional Organ/Space

Non-Healing Surgical Wounds

Microbial Stalled or Exudate Needs Granulation Needs Needs Compression,

PROMOGRAN PRISMA PROMOGRAN Matrix Wound

SILVERCEL NON-ADHERENT or SILVERCEL Antimicrobial Alginate Dressing1,2 PAGES 37-38

Minimizing dressing adherence to the wound

Secondary Dressing Primary or Secondary Dressings

V.A.C. Therapy promotes wound healing through well-established mechanisms of action